
Keywords: Antibody deficiency; Immunodeficiency; Immunoglobulin replacement; AE; Adverse event; AUC; Area under the time/concentration curve; IGHy; Immunoglobulin, hyaluronidase facilitated; IGIM; Immunoglobulin, intramuscular; IGIV; Immunoglobulin, intravenous; IG